Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares KNSA
$74.53
-2.04%
at last close
Financials (TTM)
- Revenue
- $840.85 million
- Net Income
- $80.66 million
- Net Margin
- 9.59%
- Return on Equity
- 12.33%
- Debt-to-Equity
- —
- P/E Ratio
- 76.05
- Price / Book
- 9.07
- Price / Sales
- 7.06
Over the trailing twelve months, Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares generated revenue of $840.85 million and net income of $80.66 million, a net margin of 9.59%.
At the last closing price of $74.53, KNSA trades at 76.05 times trailing earnings and 7.06 times sales, with a market capitalization of $5.94 billion.
Key Stats
- Last Close
- $74.53
- Market Cap
- $5.94 billion
- 52-Week Range
- $32.89 – $82.94
- Average Volume
- 498K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.